These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 29393142)

  • 1. Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository.
    Kato S; Ishibashi A; Kani K; Yakabi K
    Digestion; 2018; 97(1):59-63. PubMed ID: 29393142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM; Kushkuley S; Barrett JA; Oster G
    Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis.
    Yamamoto T; Shimoyama T; Matsumoto K
    Aliment Pharmacol Ther; 2015 Sep; 42(5):549-58. PubMed ID: 26140337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study.
    Watanabe M; Nishino H; Sameshima Y; Ota A; Nakamura S; Hibi T
    Aliment Pharmacol Ther; 2013 Aug; 38(3):264-73. PubMed ID: 23734840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi Matrix System Mesalazine Plus Rectal Mesalazine in the Treatment of Mild to Moderately Active Ulcerative Proctitis.
    Cuomo A; Sgambato D; D'Auria MV; Miranda A; Ferrante E; Romano M
    Dig Dis; 2018; 36(2):130-135. PubMed ID: 29339645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The usefulness of mesalazine suppositories for the treatment of lymphoid follicular proctitis].
    Seo GS; Choi SC; Jo EY; Choi CS; Kim JW; Kim TH; Yun KJ; Nah YH
    Korean J Gastroenterol; 2006 Jun; 47(6):420-4. PubMed ID: 16809948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.
    Marteau P; Crand J; Foucault M; Rambaud JC
    Gut; 1998 Feb; 42(2):195-9. PubMed ID: 9536943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
    Andus T; Kocjan A; Müser M; Baranovsky A; Mikhailova TL; Zvyagintseva TD; Dorofeyev AE; Lozynskyy YS; Cascorbi I; Stolte M; Vieth M; Dilger K; Mohrbacher R; Greinwald R;
    Inflamm Bowel Dis; 2010 Nov; 16(11):1947-56. PubMed ID: 20310020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.
    Lucidarme D; Marteau P; Foucault M; Vautrin B; Filoche B
    Aliment Pharmacol Ther; 1997 Apr; 11(2):335-40. PubMed ID: 9146772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis.
    Mantzaris GJ; Hatzis A; Petraki K; Spiliadi C; Triantaphyllou G
    Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
    Kruis W; Neshta V; Pesegova M; Alekseeva O; Andreev P; Datsenko O; Levchenko O; Abdulkhakov S; Lozynskyy Y; Mostovoy Y; Soloviev K; Dorofeyev AE; Vieth M; Stiess M; Greinwald R; Mohrbacher R; Siegmund B
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):98-106.e4. PubMed ID: 29702300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis.
    Pica R; Paoluzi OA; Iacopini F; Marcheggiano A; Crispino P; Rivera M; Bella A; Consolazio A; Paoluzi P
    Inflamm Bowel Dis; 2004 Nov; 10(6):731-6. PubMed ID: 15626890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
    Gionchetti P; Rizzello F; Venturi A; Ferretti M; Brignola C; Miglioli M; Campieri M
    Dis Colon Rectum; 1998 Jan; 41(1):93-7. PubMed ID: 9510317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
    Gionchetti P; Rizzello F; Venturi A; Brignola C; Ferretti M; Peruzzo S; Campieri M
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1053-7. PubMed ID: 9663829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group.
    d'Albasio G; Paoluzi P; Campieri M; Bianchi Porro G; Pera A; Prantera C; Sturniolo GC; Miglioli M
    Am J Gastroenterol; 1998 May; 93(5):799-803. PubMed ID: 9625131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.
    Dubois E; Moens A; Geelen R; Sabino J; Ferrante M; Vermeire S
    United European Gastroenterol J; 2020 Oct; 8(8):933-941. PubMed ID: 32631177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens.
    Farup PG; Hovde O; Halvorsen FA; Raknerud N; Brodin U
    Scand J Gastroenterol; 1995 Feb; 30(2):164-70. PubMed ID: 7732340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial].
    Ngô Y; Gélinet JM; Ivanovic A; Kac J; Schénowitz G; Vilotte J; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(10):782-6. PubMed ID: 1478406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.